ACM
CGEM icon

Aquatic Capital Management’s Cullinan Oncology CGEM Stock Holding History

Aquatic Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,923
Closed -$320K – 1428
2025
Q4 		$320K Buy
30,923
+28,141
+1,012% +$254K 0.01% 871
2025
Q3 		$16.5K Buy
+2,782
New +$20.4K ﹤0.01% 1322
2025
Q2 		– Sell
-395
Closed -$2.99K – 1273
2025
Q1 		$2.99K Sell
395
-5,962
-94% -$57.2K ﹤0.01% 1203
2024
Q4 		$77.4K Buy
+6,357
New +$91.4K ﹤0.01% 1109
2023
Q1 		– Sell
-7,200
Closed -$75K – 1316
2022
Q4 		$75K Buy
+7,200
New +$87.5K 0.01% 927

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return